Shares of Achieve Life Sciences Inc. (ACHV) are up over 30% in pre-market trading on Friday, following encouraging final data from its phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of Cytisinicline in smokers.
from RTT - Biotech https://ift.tt/2GXQOt2
via IFTTT
No comments:
Post a Comment